by Vora Corporate Finance | Jan 18, 2021 | Insights, Private Equity & IPO
Hyderabad based Gland Pharma Ltd. is an injectable-focused company with a footprint in 60 countries. Company mainly operates in complex injectable under B2B model. The issue price of the stock was kept Rs. 1490 to Rs. 1500 per share at P/E of around 30. IPO was...
by Vora Corporate Finance | Jan 16, 2021 | Insights, Private Equity & IPO
Biocon Ltd., a bio-pharmaceutical company, announced that the Board of its subsidiary Biocon Biologics Ltd (Biocon Biologics) has approved a Rs.1,125 Crore (approx. USD 150 million) fund raise from Goldman Sachs. As per the proposed terms, Goldman Sachs will be issued...
